Maxime Dely: The Human Eye – Irreplaceable Guardian of Blood Transfusion
Maxime Dely, Sales and Application Specialist in Therapeutic Apheresis and Cell Therapy, shared a post on LinkedIn:
“The human eye: Irreplaceable guardian of blood transfusion
In an era where artificial intelligence is revolutionizing medicine and robotization is transforming our laboratories, one field remains steadfast: visual control in blood transfusion.
Colorimetry: diagnosis at a glance
Every blood product tells a story through its color.
Turbid plasma? It’s lipemic.. A greenish tint? Trace of oral contraceptives. A pinkish coloration? Sign of hemolysis.
These instant observations guide our daily decisions.
Red blood cell concentrates reveal their quality through the coloration of the supernatant after storage. Simple, yet no machine can replace this human vigilance.
Swirling: when platelets dance
The most fascinating control? Platelet “swirling” – that whirling dance observed with the naked eye that testifies to their viability. An absent movement immediately alerts to degradation.
The leuko-platelet layer, with its creamy hue, also provides information on residual platelet quantity.
Expertise that cannot be digitized
These visual controls are essential safety barriers. Each professional develops a particular acuity, an abilty to perceivesubtle nuances.
This expertise is transmitted, refined – but cannot be robotized.
Blood transfusion illustrates the perfect balance between technology and human expertise. Automated systems optimize, IT systems trace, but it’s the trained eye that validates final quality.
Let’s value this human dimension
Behind every transfused bag lies the attentive gaze of a professional. In blood transfusion, the human eye remains our most precious safety instrument.”
Get the latest from Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy